TACROLIMUS

Substance profile for UNII WM0HAQ4WNM, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for TACROLIMUS
Structure render from PubChem CID 5282315

Substance Identity#

UNII
WM0HAQ4WNM
Preferred term
TACROLIMUS
Registry number
109581-93-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C44H69NO12.H2O
Chemical structure for TACROLIMUS
Structure render from PubChem CID 5282315

Chemical And Database Identifiers#

InChIKey
NWJQLQGQZSIBAF-MLAUYUEBSA-N
SMILES
O.CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC
RxCUI
484288
PubChem
5282315
NCIt
C1311
INN ID
0

Open Chemistry Sources#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMThese highlights do not include all the information needed to use PROGRAF safely and effectively. See full prescribing information for PROGRAF. PROGRAF ® (tacrolimus) capsules, USP PROGRAF ® (tacrolimus) injection, (for intravenous use) Initial U.S. Approval: 19941
tacrolimusACTIVE MOIETYWM0HAQ4WNMPROGRAF® tacrolimus capsules tacrolimus injection (for intravenous infusion only)1
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNM3b7f0fed-9046-4094-a131-29d560733e471
TACROLIMUSACTIVE MOIETYWM0HAQ4WNM3b7f0fed-9046-4094-a131-29d560733e471
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE, GELATIN COATED [BRYANT RANCH PREPACK]1000
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMPROGRAF (TACROLIMUS) CAPSULE, GELATIN COATED PROGRAF (TACROLIMUS) INJECTION, SOLUTION [ASTELLAS PHARMA US, INC.]15
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [WATSON LABORATORIES, INC.]11
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMPROTOPIC (TACROLIMUS) OINTMENT [ASTELLAS PHARMA US INC.]10
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [SANDOZ INC]10
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE, GELATIN COATED [KREMERS URBAN PHARMACEUTICALS INC.]9
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMHECORIA (TACROLIMUS) CAPSULE [NOVARTIS PHARMACEUTICALS CORPORATION]7
tacrolimusACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [DR. REDDY'S LABORATORIES LIMITED]7
tacrolimusACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS OINTMENT [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]7
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [SANDOZ INC]6
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [ACCORD HEALTHCARE INC.]5
tacrolimusACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [AMERICAN HEALTH PACKAGING]5
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [CARDINAL HEALTH]5
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [STRIDES ARCOLAB LIMITED]5
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMASTAGRAF XL (TACROLIMUS EXTENDED-RELEASE CAPSULES) CAPSULE, COATED, EXTENDED RELEASE [ASTELLAS PHARMA US, INC.]4
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [MYLAN PHARMACEUTICALS INC.]4
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMENVARSUS XR (TACROLIMUS) TABLET, EXTENDED RELEASE [VELOXIS PHARMACEUTICALS, INC]3
tacrolimusACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [CARDINAL HEALTH]2
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [MYLAN INSTITUTIONAL INC.]2
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS OINTMENT [PERRIGO NEW YORK INC]2
tacrolimusACTIVE MOIETYWM0HAQ4WNMPROGRAF (TACROLIMUS) CAPSULE, GELATIN COATED [CARDINAL HEALTH]1
tacrolimusACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [CARDINAL HEALTH]1
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [CARDINAL HEALTH]1
tacrolimusACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [INGENUS PHARMACEUTICALS, LLC]1
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [KAISER FOUNDATION HOSPITALS]1
TACROLIMUSACTIVE INGREDIENTWM0HAQ4WNMTACROLIMUS CAPSULE [MAJOR PHARMACEUTICALS]1